Response to: Pre-referral rectal artesunate in severe malaria: A flawed trial

Trials

Volumn 12, Issue , 2011, Pages

  Gomes, Melba F ^a  

^a WORLD BANK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

DISEASE SEVERITY; HEALTH CARE PERSONNEL; HUMAN; LETTER; MALARIA; MEDICAL RESEARCH; PATIENT SAFETY; METHODOLOGY; NOTE; PATIENT REFERRAL; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ANTIMALARIALS; ARTEMISININS; HUMANS; MALARIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFERRAL AND CONSULTATION; RESEARCH DESIGN;

EID: 79961103296     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-12-189     Document Type: Letter

References (2)

1. Hirji KF, Premji ZG. Pre-referral rectal artesunate in severe malaria: a flawed trial. Trials 2011, 12:188. 10.1186/1745-6215-12-188, 21824389.
2. Gomes MF, Faiz MA, Gyapong JO, Warsame M, Agbenyega T, Babiker A, Baiden F, Yunus EB, Binka F, Clerk C, Folb P, Hassan R, Hossain MA, Kimbute O, Kitua A, Krishna S, Makasi C, Mensah N, Mrango Z, Olliaro P, Peto R, Peto TJ, Rahman MR, Ribeiro I, Samad R, White NJ, . the Study 13 Research Group Pre-referral rectal artesunate to prevent death and disability in severe malaria: A placebo-controlled trial. Lancet 2009, 373:557-566. 10.1016/S0140-6736(08)61734-1, 2646124, 19059639, the Study 13 Research Group.